The contentious and complex co-payment issue, of NHS cancer patients paying privately for additional medication then being forced to finance the whole episode of their care, is set to come to a head this autumn.Professor Mike Richards, the national clinical director for cancer, will present the findings of a four-month government-commissioned review into present policy…